Signals, not fuel
Peptides are rarely consumed as raw material. They typically act as messengers that dock onto a receptor and trigger an intracellular cascade — a lock-and-key relationship that determines both the effect and its limits.
A molecule that activates a receptor is an agonist; one that blocks it is an antagonist. Many modern peptide drugs are engineered agonists of hormones the body already uses.
Fig. 02 / Molecular pathwayWhy engineering matters
Natural peptide hormones are often cleared within minutes. Medicinal chemistry addresses this with modifications — fatty acid chains, amino acid substitutions, backbone changes — that resist enzymatic breakdown and extend half-life from minutes to days.
These same modifications change distribution and immunogenicity, which is why an engineered analogue is a different medicine from the natural hormone it resembles.
- Selectivity: how narrowly the peptide hits its intended receptor.
- Half-life: how long meaningful exposure persists after a dose.
- Route: injection, topical, intranasal, or (rarely) oral with absorption enhancers.
- Immunogenicity: whether the body forms antibodies against the peptide.
Editorial disclaimer
This site is educational and does not provide medical advice, dosing protocols, or treatment recommendations. Regulatory status and evidence strength differ sharply between compounds. A “research use only” label does not indicate that a product is appropriate for human use. Decisions about medicines belong with a qualified clinician.